News
Global drugmakers, including generic drug manufacturers in India, are racing to develop their versions of blockbuster ...
Anthropic’s Mike Krieger believes AI is dissolving the boundaries between idea and execution, making solo founders more ...
For the first time, Fortune analyzed the top companies across the continent in partnership with Statista to find the ...
Deep Apple Therapeutics, Inc. has announced a research collaboration and exclusive worldwide license agreement with Novo Nordisk to discover, develop, and commercialize ...
Novo Nordisk’s drugs are being linked to an eye condition that can cause vision loss, while health tech companies made CNBC’s ...
Jensen Huang, CEO of Nvidia, said Nvidia's physical AI systems are poised to revolutionize industries, with a $50 trillion market opportunity.
Deep Apple Therapeutics Inc. could bring in as much as $812 million in a new collaboration and license deal with Novo Nordisk A/S. The total includes an unspecified up-front payment, research costs ...
Harrow licensed U.S. rights to FDA-approved BYQLOVI for post-surgical eye pain and adds momentum to its branded ophthalmic ...
Novo Nordisk and Deep Apple Therapeutics Inc. have entered a research collaboration and exclusive license agreement.
Nvidia is set to construct its inaugural artificial intelligence cloud platform for industrial use in Germany, aiming to ...
Nvidia CEO Jensen Huang announced the companys first industrial AI cloud platform will be built in Germany, unveiled during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results